Windtree Therapeutics (WINT) Institutional Ownership $1.03 +0.04 (+3.50%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Windtree Therapeutics (NASDAQ:WINT)CurrentInstitutional OwnershipPercentage29.33%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.08MNumber ofInstitutional Sellers(last 12 months)0 Get WINT Insider Trade Alerts Want to know when executives and insiders are buying or selling Windtree Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data WINT Institutional Buying and Selling by Quarter Windtree Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025Renaissance Technologies LLC119,266$42K0.0%N/A1.079% 8/7/2023Acadian Asset Management LLC31,583$39K0.0%N/A0.613% 7/27/2023Virtu Financial LLC42,667$54K0.0%N/A0.828% 11/7/2022Virtu Financial LLC100,808$30K0.0%+559.5%0.329% 10/13/2022PVG Asset Management Corp187,060$56K0.2%N/A0.611% 11/12/2021Renaissance Technologies LLC187,400$386K0.0%+28.6%0.702% 11/10/2021Skandinaviska Enskilda Banken AB publ110,500$228K0.0%+15.7%0.414% 11/9/2021BlackRock Inc.49,708$102K0.0%-13.6%0.186% 8/16/2021State Street Corp19,300$44K0.0%N/A0.072% 8/16/2021Frontier Wealth Management LLC60,000$137K0.0%N/A0.225% 8/16/2021Goldman Sachs Group Inc.66,952$153K0.0%N/A0.251% 8/13/2021Renaissance Technologies LLC145,700$334K0.0%+1,156.0%0.546% 8/13/2021Northern Trust Corp65,380$149K0.0%+28.8%0.245% 8/13/2021Geode Capital Management LLC69,082$158K0.0%N/A0.259% 8/13/2021Vanguard Group Inc.626,057$1.43M0.0%+16.1%2.344% 8/10/2021Skandinaviska Enskilda Banken AB publ95,500$219K0.0%N/A0.364% 5/21/2021Citadel Advisors LLC66,035$162K0.0%N/A0.251% 5/18/2021Citadel Advisors LLC66,035$162K0.0%N/A0.251% 5/17/2021HRT Financial LP23,365$57K0.0%N/A0.089% 5/14/2021PVG Asset Management Corp63,795$156K0.5%N/A0.243% 5/13/2021Renaissance Technologies LLC11,600$28K0.0%N/A0.044% 5/13/2021Kepos Capital LP165,000$404K0.0%+83.3%0.628% 5/12/2021Northern Trust Corp50,743$125K0.0%-29.9%0.193% 5/4/2021 Envestnet Asset Management Inc.36,334$89K0.0%N/A0.138% (Data available from 1/1/2016 forward) WINT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of WINT shares? During the previous two years, the following institutional investors and hedge funds held shares of Windtree Therapeutics shares: Virtu Financial LLC ($54K), and Renaissance Technologies LLC ($42K), Acadian Asset Management LLC ($39K).Learn more on WINT's institutional investors. What percentage of Windtree Therapeutics stock is owned by institutional investors? 29.33% of Windtree Therapeutics stock is owned by institutional investors. Learn more on WINT's institutional investor holdings. Which institutional investors have been buying Windtree Therapeutics stock? The following institutional investors have purchased Windtree Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($119.27K), Virtu Financial LLC ($42.67K), and Acadian Asset Management LLC ($31.58K). How much institutional buying is happening at Windtree Therapeutics? Institutional investors have bought a total of 193,516 shares in the last 24 months. This purchase volume represents approximately $85.61M in transactions. Related Companies PALI Institutional Ownership SNPX Institutional Ownership GENE Institutional Ownership ENVB Institutional Ownership SPRB Institutional Ownership IMCC Institutional Ownership MTNB Institutional Ownership NCNA Institutional Ownership HEPA Institutional Ownership CNSP Institutional Ownership This page (NASDAQ:WINT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
